Most notably, the importance for the role of RAP1 in DDR is provided by data from human clinical trials which shows that RAP1 levels correlate with the success of chemotherapy for breast and colon cancer using DNA damaging agents. This evidence concerns the gene TERF2IP and colonic neoplasm.